Category: biotech

.Merck &amp Co. has actually grabbed choices on two Evaxion Biotech vaccination applicants, paying out $3.2 million and hanging greater than $1 billion in landmarks

.Merck &amp Co.’s long-running attempt to land a strike on little mobile lung cancer (SCLC) has racked up a small triumph. The drugmaker’s Daiichi Sankyo-partnered

.A period 3 trial of Daiichi Sankyo and also Merck &amp Co.’s HER3-directed antibody-drug conjugate (ADC) has actually reached its own main endpoint, enhancing plans

.Gilead Sciences as well as Merck &amp Co. have guided their once-weekly HIV combination therapy past one more turning point, linking the beverage to continual

.MBX Biosciences has added to the recent flurry of IPO filings. The biotech, which submitted its own documentation weeks after raising $63.5 million independently, is

.MBX has expanded plannings to enjoy over $136 million from its IPO as the biotech aims to deliver a possible challenger to Ascendis Pharma’s rare

.Lykos Therapies may have dropped three-quarters of its own workers in the wake of the FDA’s turndown of its own MDMA candidate for trauma, yet

.Psychopharmacology has taken 3 articles about midstage medical trial data determining Lykos Rehabs’ investigational MDMA candidate for managing trauma (POST-TRAUMATIC STRESS DISORDER). The journal cited

.Following a bad showing for Lykos Therapeutics’ MDMA prospect for trauma at a recent FDA consultatory board meeting, the other footwear has dropped.On Friday, the

.Lundbeck is actually slashing guide market value of its own $250 million Abide Therapeutics buyout in response to phase 1 information that activated a very